Xia Xu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Cancer-related gene regulation 6
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 4
- Oncology 26
- PARP inhibition in cancer therapy 8
- Cancer Cells and Metastasis 6
- Co-authors
- Zhifang Liu (13 shared papers)Jihui Jia (13 shared papers)Mark W. Onaitis (7 shared papers)Yun Lu (3 shared papers)Christopher R. Futtner (3 shared papers)Brigid L.M. Hogan (3 shared papers)Jason R. Rock (2 shared papers)Cunying Ma (5 shared papers)
- Journals
- Journal of Ovarian Research (10 papers)PLoS ONE (5 papers)Cancer Research (4 papers)Journal of Cellular Biochemistry (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xia Xu
116 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 144
- Cancer Research 884
- Oncology 704
- Molecular Biology 1.8k
- Reproductive Medicine 142
- Pulmonary and Respiratory Medicine 410
Countries citing papers authored by Xia Xu
This map shows the geographic impact of Xia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Xu more than expected).
Fields of papers citing papers by Xia Xu
This network shows the impact of papers produced by Xia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Xu. The network helps show where Xia Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 200 | |
| 2 | 2018 | 181 | |
| 3 | 2010 | 176 | |
| 4 | 2020 | 147 | |
| 5 | 2018 | 97 | |
| 6 | 2013 | 92 | |
| 7 | 2017 | 90 | |
| 8 | 2008 | 75 | |
| 9 | 2020 | 73 | |
| 10 | 2019 | 72 | |
| 11 | 2014 | 71 | |
| 12 | 2012 | 71 | |
| 13 | 2009 | 67 | |
| 14 | 2015 | 65 | |
| 15 | 2014 | 64 | |
| 16 | 2020 | 64 | |
| 17 | 2013 | 62 | |
| 18 | 2016 | 62 | |
| 19 | 2013 | 59 | |
| 20 | 2013 | 56 |
About Xia Xu
Xia Xu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 123 papers that have together received 3.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), PARP inhibition in cancer therapy (8 papers), Cancer Cells and Metastasis (6 papers), Cancer-related gene regulation (6 papers), Autophagy in Disease and Therapy (5 papers), Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (884 citations), Oncology (704 citations), Molecular Biology (1.8k citations), Reproductive Medicine (142 citations) and Pulmonary and Respiratory Medicine (410 citations). Xia Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhifang Liu, Jihui Jia, Mark W. Onaitis, Yun Lu, Christopher R. Futtner, Brigid L.M. Hogan, Jason R. Rock, Cunying Ma, Xiaoxiang Chen and Fenghua Yang. Their work appears in journals such as Journal of Ovarian Research, PLoS ONE, Cancer Research, Journal of Cellular Biochemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.